Molecular approaches for HPV genotyping and HPV-DNA physical status

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Expert Reviews in Molecular Medicine

• Publication date

  2017-02-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1017/erm.2017.2PMID 28162121
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biological implications and therapeutic significance of DNA methylation regulated genes in cervical cancer.

  2016cited by this paper
• Prevalence of High-Risk Human Papillomavirus (HR-HPV) Genotypes and Multiple Infections in Cervical Abnormalities from Northern Xinjiang, China

  2016cited by this paper
• Methylation and expression of miRNAs in precancerous lesions and cervical cancer with HPV16 infection.

  2016cited by this paper
• A review of the clinical performance of the Aptima HPV assay.

  2016cited by this paper
• Identification of rearranged sequences of HPV16 DNA in precancerous and cervical cancer cases.

  2016cited by this paper
• A Suggested Approach to Simplify and Improve Cervical Screening in the United States

  2016cited by this paper
• Simultaneous detection of human papillomavirus integration and c-MYC gene amplification in cervical lesions: an emerging marker for the risk to progression

  2016cited by this paper
• Coming of age: ten years of next-generation sequencing technologies

  2016cited by this paper
• Clinical and analytical performance of the PapilloCheck HPV-Screening assay using the VALGENT framework.

  2016cited by this paper
• Human papillomavirus genotyping by Linear Array and Next-Generation Sequencing in cervical samples from Western Mexico

  2015cited by this paper
• The Role of the DNA Damage Response throughout the Papillomavirus Life Cycle

  2015cited by this paper
• Sites of disruption within E1 and E2 genes of HPV16 and association with cervical dysplasia

  2015cited by this paper
• Evolution and classification of oncogenic human papillomavirus types and variants associated with cervical cancer.

  2015cited by this paper
• Viral load, gene expression and mapping of viral integration sites in HPV16‐associated HNSCC cell lines

  2015cited by this paper
• Human papillomavirus (HPV) genome status & cervical cancer outcome - A retrospective study

  2015cited by this paper
• Duplex Real-time PCR assay and SYBR green I melting curve analysis for molecular identification of HPV genotypes 16, 18, 31, 35, 51 and 66.

  2015cited by this paper
• Comparative study of HPV16 integration in cervical lesions between ethnicities with high and low rates of infection with high-risk HPV and the correlation between integration rate and cervical neoplasia.

  2015cited by this paper
• Comparison of Human Papillomavirus Detection by Aptima HPV and cobas HPV Tests in a Population of Women Referred for Colposcopy following Detection of Atypical Squamous Cells of Undetermined Significance by Pap Cytology

  2015cited by this paper
• Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study

  2015cited by this paper
• The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology.

  2015cited by this paper
• Comparison of Analytical and Clinical Performances of the Digene HC2 HPV DNA Assay and the INNO-LiPA HPV Genotyping Assay for Detecting High-Risk HPV Infection and Cervical Neoplasia Among HIV-Positive African Women

  2015cited by this paper
• Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism

  2015cited by this paper
• Next generation sequencing in women affected by nonsyndromic premature ovarian failure displays new potential causative genes and mutations.

  2015cited by this paper
• Handbook of Research on Trends in the Diagnosis and Treatment of Chronic Conditions

  2015cited by this paper
• The PapilloCheck Assay for Detection of High-Grade Cervical Intraepithelial Neoplasia

  2015cited by this paper
• Next-generation sequencing in clinical virology: Discovery of new viruses.

  2015cited by this paper
• NGS-based approach to determine the presence of HPV and their sites of integration in human cancer genome

  2015cited by this paper
• A real-time PCR approach based on SPF10 primers and the INNO-LiPA HPV genotyping extra assay for the detection and typing of human papillomavirus.

  2015cited by this paper
• Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.

  2014cited by this paper
• Next-generation sequencing technologies: breaking the sound barrier of human genetics

  2014cited by this paper
• Ten years of next-generation sequencing technology.

  2014cited by this paper
• The human papillomavirus family and its role in carcinogenesis.

  2014cited by this paper
• HPV E6/E7 RNA In Situ Hybridization Signal Patterns as Biomarkers of Three-Tier Cervical Intraepithelial Neoplasia Grade

  2014cited by this paper
• A population-based observational study comparing Cervista and Hybrid Capture 2 methods: improved relative specificity of the Cervista assay by increasing its cut-off

  2014cited by this paper
• Sensitive Simultaneous Detection of Seven Sexually Transmitted Agents in Semen by Multiplex-PCR and of HPV by Single PCR

  2014cited by this paper
• Multiple-Integrations of HPV16 Genome and Altered Transcription of Viral Oncogenes and Cellular Genes Are Associated with the Development of Cervical Cancer

  2014cited by this paper
• Comparative study of the cervista and hybrid capture 2 methods in detecting high‐risk human papillomavirus in cervical lesions

  2014cited by this paper
• DNA polymerases drive DNA sequencing-by-synthesis technologies: both past and present

  2014cited by this paper
• Next generation sequencing technology: Advances and applications.

  2014cited by this paper
• Determination of human papillomavirus 16 physical status through E1/E6 and E2/E6 ratio analysis.

  2014cited by this paper
• Comparison of the clinical performances of the AdvanSure HPV Screening Real-Time PCR, the Abbott Real-Time High-Risk HPV Test, and the Hybrid Capture High-Risk HPV DNA Test for Cervical Cancer Screening.

  2014cited by this paper
• Multiplex PCR assay for the rapid identification of human papillomavirus genotypes 16, 18, 45, 35, 66, 33, 51, 58, and 31 in clinical samples

  2014cited by this paper
• Evaluation of the HPV typing INNO-LiPA EXTRA assay on formalin-fixed paraffin-embedded cervical biopsy samples.

  2014cited by this paper
• A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes

  2014cited by this paper
• FHACT: the FISH-based HPV-associated cancer test that detects nonrandom gain at four genomic loci as biomarkers of disease progression

  2014cited by this paper
• Analytical performance of newly developed multiplex human papillomavirus genotyping assay using Luminex xMAP™ technology (Mebgen™ HPV Kit).

  2014cited by this paper
• High-risk human papillomavirus is transcriptionally active in a subset of sinonasal squamous cell carcinomas

  2014cited by this paper
• Clinical Performance of Roche Cobas 4800 HPV Test

  2014cited by this paper
• Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability

  2014cited by this paper
• E1-Mediated Recruitment of a UAF1-USP Deubiquitinase Complex Facilitates Human Papillomavirus DNA Replication

  2014cited by this paper
• RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

  2014cited by this paper
• Oncogenic human papillomavirus genotyping by multiplex PCR and fragment analysis.

  2014cited by this paper
• Screening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study

  2013cited by this paper
• The papillomavirus E2 proteins.

  2013cited by this paper
• Comparison of the accuracy of Hybrid Capture II and polymerase chain reaction in detecting clinically important cervical dysplasia: a systematic review and meta-analysis

  2013cited by this paper
• Sequencing-Based Genotyping of Mixed Human Papillomavirus Infections by Use of RipSeq Software

  2013cited by this paper
• Detection of the human papillomavirus 58 physical state using the amplification of papillomavirus oncogene transcripts assay.

  2013cited by this paper
• Detection of high-risk human papillomavirus subtypes in cervical glandular neoplasia by in situ hybridization.

  2013cited by this paper
• Human papillomavirus multiplex ligation-dependent probe amplification assay for the assessment of viral load, integration, and gain of telomerase-related genes in cervical malignancies.

  2013cited by this paper
• Multiplex Identification of Human Papillomavirus 16 DNA Integration Sites in Cervical Carcinomas

  2013cited by this paper
• Integration sites and genotype distributions of human papillomavirus in cervical intraepithelial neoplasia.

  2013cited by this paper
• Landscape of DNA Virus Associations across Human Malignant Cancers: Analysis of 3,775 Cases Using RNA-Seq

  2013cited by this paper
• Development and Characterization of the cobas Human Papillomavirus Test

  2013cited by this paper
• Genotyping human papillomaviruses: development and evaluation of a comprehensive DNA microarray.

  2013cited by this paper
• Comparison of the analytical and clinical performances of Abbott RealTime High Risk HPV, Hybrid Capture 2, and DNA Chip assays in gynecology patients.

  2013cited by this paper
• Molecular and evolutionary analysis of HPV16 E6 and E7 genes in Greek women.

  2013cited by this paper
• The Abbott RealTime High Risk HPV test is a clinically validated human papillomavirus assay for triage in the referral population and use in primary cervical cancer screening in women 30 years and older: a review of validation studies.

  2013cited by this paper
• Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study.

  2013cited by this paper
• The cytology and DNA detection by the PapilloCheck(®) test in the diagnosis of human papillomavirus infection.

  2013cited by this paper
• Simple and rapid human papillomavirus genotyping method by restriction fragment length polymorphism analysis with two restriction enzymes

  2013cited by this paper
• Preferential sites for the integration and disruption of human papillomavirus 16 in cervical lesions.

  2013cited by this paper
• Accurate human papillomavirus genotyping by 454 pyrosequencing.

  2013cited by this paper
• Detection and Typing of Human Papilloma Virus by Multiplex PCR with Type-Specific Primers

  2012cited by this paper
• Introduction of human papillomavirus DNA screening in the world: 15 years of experience.

  2012cited by this paper
• Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape

  2012cited by this paper
• The biology and life-cycle of human papillomaviruses.

  2012cited by this paper
• Clinical Validation of a Type-Specific Real-Time Quantitative Human Papillomavirus PCR against the Performance of Hybrid Capture 2 for the Purpose of Cervical Cancer Screening

  2012cited by this paper
• Sequence variation analysis of the E2 gene of human papilloma virus type 16 in cervical lesions from women in Greece

  2012cited by this paper
• Sequence variation analysis of the E2 gene of human papilloma virus type 16 in cervical lesions from women in Greece

  2012cited by this paper
• Comparison of Next-Generation Sequencing Systems

  2012cited by this paper
• A review of methods for detect human Papillomavirus infection

  2012cited by this paper
• Non-Random Integration of the HPV Genome in Cervical Cancer

  2012cited by this paper
• HPV Detection Methods in Head and Neck Cancer

  2012cited by this paper
• Comparison of the AdvanSure Human Papillomavirus Screening Real-Time PCR, the Abbott RealTime High Risk Human Papillomavirus Test, and the Hybrid Capture Human Papillomavirus DNA Test for the Detection of Human Papillomavirus

  2012cited by this paper
• High-throughput detection, genotyping and quantification of the human papillomavirus using real-time PCR

  2012cited by this paper
• Global burden of human papillomavirus and related diseases.

  2012cited by this paper
• A population-based clinical trial comparing endocervical high-risk HPV testing using hybrid capture 2 and Cervista from the SHENCCAST II Study.

  2011cited by this paper
• Clinical Validation of the cobas 4800 HPV Test for Cervical Screening Purposes

  2011cited by this paper
• In situ detection of human papillomavirus DNA after PCR-amplification.

  2011cited by this paper
• Looking ahead: A case for human papillomavirus testing of self‐sampled vaginal specimens as a cervical cancer screening strategy

  2011cited by this paper
• Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Human papillomavirus (HPV) detection using in situ hybridization in histologic samples: correlations with cytologic changes and polymerase chain reaction HPV detection.

  2011cited by this paper
• Comparison of Real-Time Multiplex Human Papillomavirus (HPV) PCR Assays with the Linear Array HPV Genotyping PCR Assay and Influence of DNA Extraction Method on HPV Detection

  2011cited by this paper
• Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.

  2011cited by this paper
• Comparison of the PapilloCheck® assay with the digene HC2 HPV DNA assay for the detection of 13 high‐risk human papillomaviruses in cervical and anal scrapes

  2011cited by this paper
• Human papillomavirus detection and typing using a nested-PCR-RFLP assay.

  2011cited by this paper
• Clinical performance of the CLART human papillomavirus 2 assay compared with the hybrid capture 2 test

  2011cited by this paper
• Small Molecule Inhibitors of Human Papillomavirus Protein - Protein Interactions

  2011cited by this paper
• Novel Microsphere-Based Method for Detection and Typing of 46 Mucosal Human Papillomavirus Types

  2011cited by this paper

• Prevalence and Genotype Distribution of High-Risk HPV Genotypes Among Women in Greece: A Retrospective Analysis of 3500 Women

  2025influential citation
• Disruption Events in the HPV18 E1 and E2 Genes in Precancerous Cervical Lesions

  2025influential citation
• Detection of partial deletions of the human papillomavirus 16 E6 gene in a subset of oropharyngeal and cervical cancers

  2025cites this paper
• Evolution of testing for the diagnosis of human papillomavirus (HPV) status in head and neck squamous cell carcinoma: Where from and where to?

  2025cites this paper
• Current insights on human Papillomavirus-independent cervical cancers: a systematic review

  2025cites this paper
• Design and Development of a Target Amplification‐Free Microfluidic Platform for Human Papillomavirus Genotyping: A New Generation of Hybrid Capture Immunoassay

  2025cites this paper
• Prevalence and genotype distribution of human papillomavirus infection among Kurdish people, Iran

  2025influential citation
• In Situ Colorimetric LAMP Based on One-Step Modified Filter Paper to Screen Human Papillomavirus (HPV)16/18 from Clinical Samples

  2024cites this paper
• HPV-16 E6 mutation and viral integration related host DNA methylation implicate the development and progression of cervical cancer

  2024cites this paper
• Research progress on human papillomavirus-negative cervical cancer: A review

  2024cites this paper
• Long-read sequencing reveals the structural complexity of genomic integration of HPV DNA in cervical cancer cell lines

  2024cites this paper
• Comparison of diagnostic accuracy and acceptability of self-sampling devices for human Papillomavirus detection: A systematic review

  2024cites this paper
• The analysis of HPV integration sites based on nanopore sequencing and the profiling changes along the course of photodynamic therapy

  2023cites this paper
• Genomica in Sanità Pubblica Evidenze scientifiche e prospettive di integrazione nella pratica della prevenzione

  2023influential citation
• Immunostaining of βA-Activin and Follistatin Is Decreased in HPV(+) Cervical Pre-Neoplastic and Neoplastic Lesions

  2023cites this paper
• Label-free Detection of Virus Based on Surface-Enhanced Raman Scattering

  2023cites this paper
• Human Papillomavirus 16 DNA Methylation Patterns and Investigation of Integration Status in Head and Neck Cancer Cases

  2023cites this paper
• Increased expression of HPV-E7 oncoprotein correlates with a reduced level of pRb proteins via high viral load in cervical cancer

  2023cites this paper
• Mutation Profile of HPV16 L1 and L2 Genes in Different Geographic Areas

  2022cites this paper
• High-Risk Human Papillomavirus Detection via Cobas® 4800 and REBA HPV-ID® Assays

  2022cites this paper
• The role of HPV DNA testing in the prevention of cervical cancer

  2022influential citation
• Correlation between HPV PCNA, p16, and p21 Expression in Lung Cancer Patients

  2022cites this paper
• The Involvement of Human Papilloma Virus in Gastrointestinal Cancers

  2022cites this paper
• Anal and cervical human papillomavirus genotypes in women co-infected with human immunodeficiency virus: A systematic review

  2022cites this paper
• Cervical Intraepithelial Neoplasia Grade 3 in a HPV-Vaccinated Patient: A Case Report

  2022cites this paper
• Preliminary establishment and validation of a loop-mediated isothermal amplification assay for convenient screening of 13 types of high-risk human papillomaviruses in cervical secretions.

  2022cites this paper
• Partner-Level and Sexual Networking Factors Are Associated With Vaccine-Type and Nonvaccine-Type Human Papillomavirus Infection After Vaccine Introduction in Young Women

  2022cites this paper
• Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers

  2021cites this paper
• A Colorimetric IsoPCR for the rapid and sensitive visual detection of high-risk HPV16 in clinical samples with hydroxynaphthol blue.

  2021cites this paper
• Human Papillomavirus-Negative Cervical Cancer: A Comprehensive Review

  2021cites this paper
• Multiplex Visualized Closed-Tube PCR with Hamming Distance 2 Code for 15 HPV Subtype Typing.

  2021cites this paper
• A Sample-In-Answer-Out Microfluidic System for the Molecular Diagnostics of 24 HPV Genotypes Using Palm-Sized Cartridge

  2021cites this paper
• In Silico Design and Immunological Studies of Two Novel Multiepitope DNA-Based Vaccine Candidates Against High-Risk Human Papillomaviruses

  2021cites this paper
• Impact of human papillomavirus in sinonasal cancer—a systematic review

  2021cites this paper
• Immunological responses and anti-tumor effects of HPV16/18 L1-L2-E7 multiepitope fusion construct along with curcumin and nanocurcumin in C57BL/6 mouse model.

  2021cites this paper
• Design of Experiments to Achieve an Efficient Chitosan-Based DNA Vaccine Delivery System

  2021cites this paper
• Human papillomavirus-independent cervical cancer

  2021cites this paper
• HPV16-Genotyper: A Computational Tool for Risk-Assessment, Lineage Genotyping and Recombination Detection in HPV16 Sequences, Based on a Large-Scale Evolutionary Analysis

  2021cites this paper
• Genetic variability of the HPV16 early genes and LCR. Present and future perspectives

  2021cites this paper
• Development of a sensitive and specific nanoparticle‐assisted PCR assay for detecting HPV‐16 and HPV‐18 DNA

  2020cites this paper
• Methodologies of Primary HPV Testing Currently Applied for Cervical Cancer Screening

  2020cites this paper
• Comparison of HPV detection rate in formalin-fixed paraffin-embedded tissues of head and neck carcinoma using two DNA extraction kits and three amplification methods.

  2020cites this paper
• HRRD: a manually-curated database about the regulatory relationship between HPV and host RNA

  2020cites this paper
• Cervical cancer risk profiling: molecular biomarkers predicting the outcome of hrHPV infection

  2020cites this paper
• Internally controlled recombinase-aided amplification (IC-RAA) assays for the detection of human papillomavirus genotypes 16 and 18 using extracted DNA and samples treated with nucleic acid releasing agent

  2020cites this paper
• The correlation of HPV16 and HPV18 with local vaginal immunity after the treatment of cervical intraepithelial neoplasia

  2020cites this paper
• Incidence and Prevalence of Human Papilloma Virus-associated Cancers in IBD.

  2020cites this paper
• WarmStart colorimetric LAMP for the specific and rapid detection of HPV16 and HPV18 DNA.

  2019cites this paper
• DETECTION OF HUMAN PAPILLOMAVIRUS GENOTYPES IN CANCER CERVIX PATIENTS: DAMIETTA GOVERNORATE, EGYPT

  2019cites this paper
• Human Papillomavirus Infections, Cervical Cancer and MicroRNAs: An Overview and Implications for Public Health

  2019cites this paper
• Screening for Human Papillomavirus in a Low- and Middle-Income Country

  2019cites this paper
• Α 2-stage, nested-like nucleic acid amplification method (IsoPCR) for the highly sensitive detection of HPV16 and HPV18 DNA.

  2019cites this paper
• Association of p16 (CDKN2A) polymorphisms with the development of HPV16‐related precancerous lesions and cervical cancer in the Greek population

  2018cites this paper
• Polymorphic variability in the exon 19 of the RB1 gene and its flanking intronic sequences in HPV16‐associated precancerous lesions in the Greek population

  2018cites this paper
• Association of codon 72 polymorphism of p53 with the severity of cervical dysplasia, E6‐T350G and HPV16 variant lineages in HPV16‐infected women

  2017cites this paper